Bank Julius Baer & Co. Ltd, Zurich Arcturus Therapeutics Holdings Inc. Transaction History
Bank Julius Baer & Co. Ltd, Zurich
- $34.2 Billion
- Q3 2025
A detailed history of Bank Julius Baer & Co. Ltd, Zurich transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Bank Julius Baer & Co. Ltd, Zurich holds 800 shares of ARCT stock, worth $5,816. This represents 0.0% of its overall portfolio holdings.
Number of Shares
800
Previous 2,300
65.22%
Holding current value
$5,816
Previous $29,000
51.72%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ARCT
# of Institutions
173Shares Held
26MCall Options Held
2.32MPut Options Held
866K-
Federated Hermes, Inc. Pittsburgh, PA4.69MShares$34.1 Million0.16% of portfolio
-
Black Rock Inc. New York, NY2.65MShares$19.3 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.1.95MShares$14.2 Million0.39% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.95MShares$14.2 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.89MShares$13.7 Million0.0% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $193M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...